EpiAxis has appointed The Sage Group to lead the partnering program for its peptide candidates which modulate the epigenetic control of metastatic cancer.
http://gulfstrategic.com/gc/wp-content/uploads/logo_final.jpg00PR PRhttp://gulfstrategic.com/gc/wp-content/uploads/logo_final.jpgPR PR2019-08-12 03:01:422019-08-12 05:08:32EpiAxis Therapeutics Announces Search for Strategic Partners for Leadership in Epigenetic Control of Metastatic Cancer – EIN News
